CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Camurus AB Company Snapshot
Camurus AB operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Camurus AB with three other pharmaceutical manufacturers in Europe: Collagen Solutions PLC of the United Kingdom (2017 sales of £3.95 million [US$5.01 million] ), Paion AG of Germany (5.81 million Euro [US$6.60 million] of which 100% was Pharmaceutical), and Enzymatica AB (publ) (59.45 million Swedish Kronor [US$6.46 million] of which 100% was Medical Devices).

Sales Analysis.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Camurus AB
  Stock Performance Chart for Camurus AB
 
  Stock Data: Recent Stock Performance:
  Current Price (8/17/2018): 96.20
(Figures in Swedish Kronor)
1 Week -0.5%   13 Weeks 1.5%  
4 Weeks -6.4%   52 Weeks -21.0%  
 
Camurus AB Key Data:
  Ticker: CAMX Country: Sweden
  Exchanges: STO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 54,308,000
(Year Ending Jan 2018).
Employees: 71
  Currency: Swedish Kronor Market Cap: 3,692,298,953
  Fiscal Yr Ends: December Shares Outstanding: 38,381,486
  Share Type: Aktie Closely Held Shares: 22,974,183
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.